The diagnostic value of additional research in giant cell arteritis

The diagnostic value of additional research in giant cell arteritis - The diagnostic value of additional research in giant cell arteritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39789

Enrollment

125

Registered

2012-07-12

Start date

2012-06-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

giant cell arteritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: suspicion of giant cell arteritis in a patient older than 50 years with at least 2 additonal points: - increased ESR and/or CRP - new onset headache, temporal or occipital -visual deterioration, blindness, diplopia -jaw claudication -tender temporal artery, pressure sensitive

Exclusion criteria

Exclusion criteria: another form of vasculitis incompetence

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity and positive predictive value of history and physical examination in patients with suspected giant cell arteritis compared with the biopsy of the temporal artery Sensitivity and specificity of ultrasonography of the temporal arteries compared with the biopsy of the temporal artery	—

Secondary

Measure	Time frame
The duration of ultrasonographic abnormalities, that persist after starting steroid therapy. Change of ultrasonographic abnormalities in time, after start of therapy with corticosteroids Change of ultrasonographic abnormalities in recurrent symptoms or increase in inflammatory parameters.	—

Countries

Netherlands

Outcome results